$0.0174
-0.0226-56.5%
Last update: Nov 10, 7:59 PM
Karyopharm Therapeutics Inc
KPTINASDAQ
The average analyst price target for Karyopharm Therapeutics is $32.50, 201763.4% above the current price. Of 7 analysts, 5 rate it Buy and 2 Hold. Targets range from $3 to $75. The latest change came on Nov 2, 2026, when Rodman & Renshaw downgraded Karyopharm Therapeutics from Buy to Neutral.
Price Target Range — 11 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
